Extracorporeal Membrane Oxygenation in Myocardial Infarction Complicated by Cardiogenic Shock: Analysis of the ELSO Registry

Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) has high mortality despite contemporary therapy, with no survival benefit demonstrated from Impella (Abiomed, Danvers, Massachusetts) or intra-aortic balloon pump (IABP) in randomized trials ([1][1],[2][2]). The pathophysiology